Literature DB >> 2173266

Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene.

C Edbauer1, R Weinberg, J Taylor, A Rey-Senelonge, J F Bouquet, P Desmettre, E Paoletti.   

Abstract

A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) strain Texas was generated. Immunoprecipitation with chicken anti-NDV serum confirmed authentic expression of the HN protein. Protection of chickens from infection with NDV was observed when birds were immunized with the recombinant HN fowlpox virus by the intramuscular route after one or two inoculations. Vaccination by the ocular route with a mixture of fowlpox recombinants expressing the fusion and HN proteins did not show added protection over that seen with the individual viruses.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2173266     DOI： 10.1016/0042-6822(90)90165-n

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  9 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Non-replicating expression vectors: applications in vaccine development and gene therapy.

Authors:  K J Limbach; E Paoletti
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

Review 3.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease.

Authors:  Man-Seong Park; John Steel; Adolfo García-Sastre; David Swayne; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

5.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter.

Authors:  E Nagy; P J Krell; R A Heckert; J B Derbyshire
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

7.  Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.

Authors:  J B Moore; G L Smith
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

Review 8.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

Review 9.  Recombinant fowlpox virus vaccines for poultry.

Authors:  D B Boyle; H G Heine
Journal:  Immunol Cell Biol       Date:  1993-10       Impact factor: 5.126
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.